Efficacy News and Research

RSS

Groundbreaking discovery could transform leishmaniasis treatment

Leishmaniasis, a neglected tropical disease prevalent across 90 countries, affects approximately 12 million people worldwide, with 350 million more at risk of infection.

24 Sep 2025

Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.

23 Sep 2025

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Osteoporosis is a degenerative disease characterized by decreased bone mass and damage to bone microarchitecture, as well as increased bone fragility.

23 Sep 2025

Experts call for coordinated global action to make the most of Alzheimer’s treatments

The approval of new antibody medications for Alzheimer's disease – lecanemab and donanemab – and diagnostic tests in the blood mark the beginning of a new era in Alzheimer's disease diagnosis and treatment.

23 Sep 2025

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™.

23 Sep 2025

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

Chong Hyun Shin, a research associate professor in the Institute for Biomedical Sciences at Georgia State University, has received a $25,000 grant to develop mechanisms for treating obesity and obesity-related metabolic dysfunctions.

23 Sep 2025

Simple hospital menu changes could deliver major health and climate benefits

Research indicates that optimizing hospital menus can lower carbon emissions and saturated fat consumption, promoting healthier dining options for patients.

22 Sep 2025

PRMT5 inhibition induces ferroptosis and enhances immunotherapy efficacy in renal cell carcinoma

Ferroptosis, a regulated cell death mechanism, is emerging as a promising target for cancer therapy. The process is mediated by the activity of acyl-CoA synthetase family member 4 (ACSL4) protein.

22 Sep 2025

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists (dual agonists such tirzepatide).

21 Sep 2025

Local abaloparatide injection promotes alveolar bone augmentation in orthodontic models

Alveolar bone, the specialized tissue within the jawbone, plays an important role in periodontal health.

19 Sep 2025

Can eating style affect how well GLP-1 drugs control diabetes and weight?

Research indicates that external eating behavior is a key predictor of weight loss in type 2 diabetes patients receiving GLP-1 receptor agonists.

19 Sep 2025

App boosts antibiotic prescribing safety in outpatient clinics

A smartphone app integrating antibiotic guidelines improved prescribing practices and adherence to antimicrobial stewardship in Abu Dhabi's outpatient settings.

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

New class of antibiotics shows potent activity against multidrug-resistant bacteria

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's most dangerous multidrug-resistant (MDR) bacteria.

18 Sep 2025

Real-time blood testing shows promise for preventing maternal deaths from hemorrhage

Previous
1
...
51
52
53
54
55
56
57
...
1332
Next

Efficacy News and Research

Groundbreaking discovery could transform leishmaniasis treatment

Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

Targeting miR-378 could offer a dual-action strategy against osteoporosis

Experts call for coordinated global action to make the most of Alzheimer’s treatments

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

Simple hospital menu changes could deliver major health and climate benefits

PRMT5 inhibition induces ferroptosis and enhances immunotherapy efficacy in renal cell carcinoma

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Local abaloparatide injection promotes alveolar bone augmentation in orthodontic models

Can eating style affect how well GLP-1 drugs control diabetes and weight?

App boosts antibiotic prescribing safety in outpatient clinics

New findings support low-dose ATG to delay progression of type 1 diabetes

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

New class of antibiotics shows potent activity against multidrug-resistant bacteria

Real-time blood testing shows promise for preventing maternal deaths from hemorrhage

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

electronRx to launch pDx app for remote chronic respiratory disease management

University of Maine team develops sustainable method to cut drug production costs

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News